< formatted article >

The Hidden Profit Machine: How Connecticut Hospitals Are Gaming a Federal Drug Program

A Program Meant to Help Patients—Now a Hospital Cash Cow

Connecticut’s lawmakers have quietly engineered a substantial overhaul of a federal drug discount program, transforming what was once a public health safeguard into a lucrative profit pipeline for hospitals. The result? A system where hospitals buy critical medications at a fraction of their true cost, then bill patients and insurers the full price—with the difference funneling straight into hospital coffers.

This isn’t a minor adjustment—it’s a large-scale exploitation of a program originally designed to assist low-income and uninsured patients. A last-minute amendment buried in a routine bill expanded the 340B program, now allowing hospitals to leverage extreme discounts while keeping the savings for themselves.

The Sham of Geographic Restrictions

The program was never meant to be a free-for-all. Hospitals were required to serve underserved, low-income communities—yet two-thirds of pharmacies handling these discounted drugs operate outside their designated areas, often in affluent or even out-of-state locations.

Where Does the Money Go? Straight to Hospital Bottom Lines

Lawmakers sold the 340B program as a way to lower healthcare costs for the most vulnerable. Today, it functions more like a shadow revenue stream for hospitals:

• Hospitals qualify for deeper discounts by artificially inflating their share of low-income patient care—sometimes through legal loopholes that sidestep oversight.
• During a public hearing, a UConn Health executive testified under oath that patient savings are rare—meaning the discounts rarely trickle down to those who need them.
• Proposals to force hospitals to pass on the discounts were silently killed before ever reaching a vote.

The Hidden Cost to Connecticut Families

Every year, Connecticut businesses absorb an extra $121 million in healthcare expenses because insurers and patients aren’t receiving the promised discounts. That money doesn’t disappear—it inflates healthcare costs for everyone, making care more expensive for struggling families.

Can the 340B Program Still Fulfill Its Original Purpose?

Yes—but only if lawmakers stop expanding its loopholes and start enforcing its rules.

The 340B program doesn’t have to be a corporate profit scheme. It can—and should—return to its mission: helping patients who need it most.

Will Connecticut’s leaders act—or will they keep looking the other way while hospitals rake in the profits?